CD274 and neoplasm: In addition, Programmed death ligand 1 (PD-L1, CD274), expressed on tumor and/or immune cells in the TME, interacts with PD-1 on tumor-infiltrating lymphocytes, attenuating effector T-cell responses and allowing tumors to escape immune attack (22, 23).